American Portfolios Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
American Portfolios Advisors's EW Position: Q3 2022 in Review
American Portfolios Advisors reduced its Edwards Lifesciences (EW) stake by 3.8% in Q3 2022, selling an estimated $106K and leaving 27,922 shares worth $2.31M. The position accounts for 0.1% of the portfolio, ranked #212.
American Portfolios Advisors first reported a position in EW in Q4 2017 and has held it in 20 quarters since. The position peaked at $5.05M in Q4 2021. 1,246 funds tracked by Wall St. Rank hold EW as of Q3 2022.
- American Portfolios Advisors held 27,922 shares of Edwards Lifesciences worth $2.31M as of Q3 2022.
- American Portfolios Advisors sold 1,102 Edwards Lifesciences shares in Q3 2022, an estimated $106K.
- Edwards Lifesciences made up 0.1% of American Portfolios Advisors's portfolio in Q3 2022, its #212 holding.
- American Portfolios Advisors first reported a position in Edwards Lifesciences in Q4 2017 and has held it in 20 quarters since.
- American Portfolios Advisors's Edwards Lifesciences position peaked at $5.05M in Q4 2021.
- 1,246 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2022.
Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.